Clinical trial
Safety and Efficacy Study of Brimonidine in Patients With Glaucoma or Ocular Hypertension
NCT00652483 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy Study of Brimonidine in Patients With Glaucoma or Ocular Hypertension
- Lead sponsor
- Allergan
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 31, 2003
- Completion date
- September 30, 2004
- Enrollment
- 433 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.